Back to results
US 8,772,244 B2Granted
Tubulin inhibitors
AssigneeR&D-Biopharmaceuticals GmbH
InventorWolfgang Richter
Life of this patent
Estimating the term…
Abstract
The present invention relates to novel tubulin binding molecules of formula (I) and their use for the treatment of cancer and other diseases.
Claims11
Compound of formula (I):
- wherein
- R is H or an alkyl, alkenyl, alkynyl, CO-alkyl or heteroalkyl group, all of which may optionally be substituted;
- R′ is H or an alkyl, alkenyl, alkynyl, CO-alkyl or heteroalkyl group, all of which may optionally be substituted;
- R″ is a group of formula —CH2OH or
- n is 0, 1, 2, 3, 4 or 5;
- Y is independently optionally substituted alkyl, heteroalkyl, halogen, CN, NO2 or OH;
- or a pharmacologically acceptable salt, solvate, hydrate or a pharmacologically acceptable formulation thereof.
4 more elements
Dependencies are inferred from the claim text.